Human papillomavirus vaccine recombinant monovalent - Virionics

Drug Profile

Human papillomavirus vaccine recombinant monovalent - Virionics

Alternative Names: CerVax; Human papillomavirus type 16 L1 virus-like particle vaccine - Virionics

Latest Information Update: 27 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Virionics
  • Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Human papillomavirus infections

Most Recent Events

  • 27 Mar 2008 Discontinued - Phase-I/II for Human papillomavirus infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top